Rhythm Pharmaceuticals (RYTM) Reports In-Line Q1 EPS, provides guidance

Go back to Rhythm Pharmaceuticals (RYTM) Reports In-Line Q1 EPS, provides guidance
(NASDAQ: RYTM) Delayed: 116.01 +0.53 (0.46%)
Previous Close $115.48    52 Week High
Open $115.40    52 Week Low
Day High $116.66    P/E N/A 
Day Low $114.44    EPS
Volume 50,820